New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

近段时间，美国FDA药物评价和研究中心（CDER）发布了2024创新药年度报告。数据显示，2024年CDER共批准了50个创新药，超过近五年获批创新药数量的平均水平。其中66%创新药使用了一项或多项加快开发和审评的方法，罕见病用药稳占半壁江山。抗体在 ...

Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia. The recommendation by the EMA's ...

The tissue factor pathway inhibitor (TFPI) antagonist, given as a subcutaneous injection, has been cleared to prevent or reduce bleeding episodes in patients aged 12 years and older with ...

Department of Critical Care Medicine, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China The name of disseminated intravascular coagulation (DIC) and its diagnostic ...

Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

没有更多了 ...

Sepsis is defined as a life-threatening dysfunction due to a dysregulated host response to infection. It is a common and complex syndrome and is the leading cause of death in intensive care units. The ...

Correspondence to: Prof. M Levin, Department of Paediatrics, Faculty of Medicine, Imperial College of Science, Technology & Medicine, Norfolk Place, London W2 1PG, UK; m.levin{at}ic.ac.uk Neisseria ...

2024年12月中美欧批准上市新药盘点我国批准16款新药上市陈倩统计显示，2024年12月，中国批准上市的新药数量为16款，其中有两款是我国自主研发的新药；美国批准8款新药上市；欧盟批准1款新药上市。